Most insightful knowledge platform for professionals who wish to eradicate Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi, or viruses are exposed to antibiotics, antifungals, or antivirals. As a result, the antimicrobials become ineffective and infections may persist.
Mission of AMR Insights
Our mission is to inform, educate and connect professionals to make the world free from AMR.
What you can expect in 2019:
- Informing: Our professional E-newsletter
- Educating: Masterclass & courses on AMR
- Connecting: International matchmaking symposia (2)
Maarten van Dongen
Dr Maarten van Dongen studied Molecular and Medical Microbiology at the University of Groningen and obtained his PhD in Biochemistry at the University of Amsterdam. He has lead several large projects in the domain of AMR for various Dutch authorities. At the request of the Dutch Ministry of Health, Welfare and Sports VWS, he designed a national cooperation structure for the research and development of new antibiotics.
Enriching scientific and educational gathering, which will shed light on latest advances in research and practice.
Companies and academic groups that are working on point-of-care rapid diagnostic tests to address antimicrobial resistance (AMR), who may be interested in competing to win, or who are already registered to compete in the Longitude Prize.
Global views, local problems: Innovative solutions to AMR and infection challenges
Pakistan: Increasing antibiotic resistance 20 March, 2019 - While research tries to find the treatment for antibiotic resistance, so far prevention by controlling the over prescription and overuse of the ‘wonder drug’ among humans and food animals is the only cure available in Pakistan.
Bacteria ‘Trap’ Could Help Slow Down Antibiotic Resistance 19 March, 2019 - Scientists have developed a new and faster test for identifying how single bacteria react to antibiotics, which could help in the fight against antimicrobial resistance. 
Gene That Increases Risk of Antibiotic Reaction is Identified 19 March, 2019 - Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.